Search for Clinical Trial Results
Human T-cell Leukemia Virus Type 1 - 25 Studies Found
Status | Study |
Recruiting |
Study Name: Evaluation of Patients With HAM/TSP Condition:
Date: 1999-11-03 |
Completed |
Study Name: Ciclosporin in HTLV-1 Associated Myelopathy/ Tropical Spastic Paraparesis (HAM/TSP) Condition: HTLV I Associated Myelopathy Date: 2008-10-15 Interventions: Drug: ciclosporin Ciclosporin 2.5 - 5mg/kg/day in two equally divided doses. dose adjusted according to |
Completed |
Study Name: A Study of Familial and Genetic Aspects of Adult T-Cell: Leukemia/Lymphoma , Tropical Spastic Paraparesis, and Infective Dermatitis Condition: HTLV-I Date: 2006-06-19 |
Completed |
Study Name: Pilot Study of Combination Therapy With CHOP-Zenapax (CHOP-daclizumab) Condition: HTLV-I Associated Adult T-cell Leukaemia/Lymphoma (ATLL) Date: 2011-08-16 Interventions: Drug: CHOP-daclizumab Other Name: CHOP-Zenapax |
Completed |
Study Name: Use of Pentoxifylline in Human T-lymphotropic Virus Type-1 (HTLV-1) Diseases Condition:
|
Terminated |
Study Name: The HAM Infliximab Study Condition: HTLV-I-associated Myelopathy Date: 2009-01-14 Interventions: Drug: Infliximab Infliximab 3mg/kg infused intravenously at weeks 0, 2 and 8 and then every 8 weeks unti |
Recruiting |
Study Name: Sensorimotor Exercises in Virtual Reality Platform in Individuals With Human T-lymphotropic Virus Condition: HTLV-1 Date: 2016-08-11 Interventions: Other: Video game The protocol sensorimotor exercises consist of a virtual game that attaches to the Nin |
Enrolling by invitation |
Study Name: Evaluation of InnoLIA HTLV I/II Score Condition: Human T-Lymphotrophic Virus Type I and/or Type II Date: 2010-06-22 Interventions: Device: InnoLIA HTLV I/II Score line immunoassay This intervention consists of testing a residual serum |
Terminated |
Study Name: Safety and Efficiency Study of Valproic Acid In HAM/TSP Condition: HTLV-I-Associated Myelopathy Date: 2007-08-20 Interventions: Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year. |
Completed |
Study Name: Anti-Tac for Treatment of Leukemia Condition:
Date: 2000-01-18 Interventions: Biological: daclizumab Other Name: Zenapax |